BASF: PA66PBT products encounter force majeure
On April 21, BASF stated that the company had received a force majeure notice from raw material suppliers. Raw materials such as adiponitrile (ADN), hexamethylene diamine (HMD), and AH-salt will all reduce the supply. This directly affected the supply of BASF's PA66 products (Ultramid® A and Ultramid® C, Capron® PA66). Therefore, BASF announced that all PA66-based products have encountered force majeure, effective immediately.
At this stage, the duration of force majeure is unpredictable.
Looking for chemical products? Let suppliers reach out to you!
You May Interested In
2026-07-13
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
The Crop Protection Patent Cliff Is Here
-
BASF's Intensified Moves from May to June: Plant Closures, Divestitures, and Transformation in Sync
-
EU Clears Carlyle's Acquisition of BASF's Coatings Business, but Demands Divestment of Nouryon's Polysulfide Assets: What Are the Underlying Risks?
-
BASF, Covestro, Huntsman Raise MDI Prices in North America Amid Global Supply Crunch
-
BASF Launches Global Expansion Plan for Aroma Ingredients
-
BASF Launches Global Expansion Plan for Aroma Ingredients
-
BASF’s €8.7 Billion Zhanjiang Verbund Site Fully Operational
-
BASF and Hannong Chemical Joint Venture Nonionic Surfactant Plant Begins Operation in South Korea
-
BASF Battles Market Turmoil as Profits Slide
-
BASF increases prices for MDI in ASEAN countries
Recommend Reading
-
Notice of 2026 Chinese New Year Holiday
-
China’s API Export Shift Takes Center Stage at API China 2026
-
International Workers' Day Holiday Notice and Service Arrangement
-
New Location, New Horizon: ECHEMI Thailand Branch Embarks on a New Chapter
-
Address Change Declaration（ECHEMI SPECIALTIES)
-
Change Rate Remains Positive, This Round of Refined Oil Retail Prices in China Is About to Increase
-
Pfizer Lifts 2025 Profit Forecast After Q2 Earnings Beat Sales Hit $14.65 Billion Shares Jump 2.8 Percent
-
Sandoz Set to Slash Canadian Weight-loss Drug Prices by Up to 70 Percent Generics Could Expand Patient Access
-
Vendor Shipment Surge Halts Mid-October PC Price Increase
-
Korea MFDS Proposes Major Edits to Imported Food Hygiene Rules Deadline for Public Comments Set for August 20